Cardinal Health 2015 Annual Report Download - page 73

Download and view the complete annual report

Please find page 73 of the 2015 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 91

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91

Directors, Exceutive Officers, and Corporate Governance
Cardinal Health | Fiscal 2015 Form 10-K 72
Directors, Executive Officers and Corporate Governance
The following is a list of our executive officers:
Name Age Position
George S. Barrett 60 Chairman and Chief Executive Officer
Michael C. Kaufmann 52 Chief Financial Officer
Donald M. Casey Jr. 55 Chief Executive Officer, Medical segment
Jon L. Giacomin 50 Chief Executive Officer, Pharmaceutical segment
Craig S. Morford 56 Chief Legal and Compliance Officer
Patricia B. Morrison 56 Executive Vice President, Customer Support Services and Chief Information Officer
Carole S. Watkins 55 Chief Human Resources Officer
Stephen T. Falk 50 Executive Vice President, General Counsel and Corporate Secretary
Meghan M. FitzGerald 44 Executive Vice President, Health Policy and Strategy
The business experience summaries provided below for our executive officers describe positions held during the last five years (unless
otherwise indicated).
Mr. Barrett has served as Chairman and Chief Executive Officer since August 2009.
Mr. Kaufmann has served as Chief Financial Officer since November 2014. From August 2009 until November 2014, he served as Chief
Executive Officer, Pharmaceutical segment.
Mr. Casey has served as Chief Executive Officer, Medical segment, since April 2012. Before joining us, he served as Chief Executive Officer
of the Gary and Mary West Wireless Health Institute, a non-profit research organization focused on lowering the cost of healthcare through
novel technology solutions, from March 2010 to March 2012.
Mr. Giacomin has served as Chief Executive Officer, Pharmaceutical segment since November 2014. From January 2011 until November
2014, he served as President, U.S. Pharmaceutical Distribution. Prior to that, he served as Executive Vice President, Pharmaceutical Operations
from July 2008 to January 2011.
Mr. Morford has served as Chief Legal and Compliance Officer since May 2009.
Ms. Morrison has served as Executive Vice President, Customer Support Services and Chief Information Officer since June 2011, and prior
to that was Executive Vice President and Chief Information Officer from August 2009 until June 2011.
Ms. Watkins has served as Chief Human Resources Officer since 2000.
Mr. Falk has served as Executive Vice President, General Counsel and Corporate Secretary since May 2009.
Ms. FitzGerald has served as Executive Vice President, Health Policy and Strategy since May 2015. From October 2010 until May 2015, she
served as President, Specialty Solutions. Prior to that, she was Senior Vice President, New Markets International Division and Business
Development, with Medco Health Solutions, Inc. from March 2008 to July 2010. From January 2006 until March 2008, Ms. FitzGerald was
Vice President and Chief Business Officer with Vion Pharmaceuticals, Inc. ("Vion"). Vion filed a voluntary petition for reorganization under
Chapter 11 of the U.S. Bankruptcy Code in December 2009 and filed a Chapter 11 Plan of Liquidation in February 2010.
We have adopted Standards of Business Conduct that apply to all of our directors, officers and employees. The Standards of Business Conduct
outline our corporate values and standards of integrity and behavior and are designed to protect and promote our reputation. The full text of
the Standards of Business Conduct is posted on our website at www.cardinalhealth.com under “About us — Corporate Governance —
Environmental, Social and Governance — Ethics and Compliance.”
Any waiver of the Standards of Business Conduct for directors or executive officers must be approved by the Audit Committee. As required
under SEC and New York Stock Exchange rules, we will disclose future amendments to our Standards of Business Conduct and waivers from
the Standards of Business Conduct for our principal executive officer, principal financial officer, and principal accounting officer, or persons
performing similar functions, and our other executive officers and directors on our website within four business days following the date of the
amendment or waiver.
The other information called for by Item 10 of Form 10-K is incorporated by reference to our Definitive Proxy Statement (which will be filed
with the SEC pursuant to Regulation 14A under the Exchange Act) relating to our 2015 Annual Meeting of Shareholders (our “2015 Proxy
Statement”) under the captions “Proposal 1—Election of Directors,” “Section 16(a) Beneficial Ownership Reporting Compliance” and “Corporate
Governance.”